Clinical TrialsSearch results
Number of results: 2568
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- The mammillary body amd aging
- Patients with intact mammilary bodies, lacking intracranial hemorrahegs or space-occupying lesions
- Tsutsumi Tsutsumi Satoshi
- 2022-10-16
Recruiting
- Anatomy of the cerebral cortical veins in response to positional changes: Magnetic resonance imaging study
- None
- Tsutsumi Satoshi
- 2023-09-25
Recruiting
- A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
- Prevention of primary CMV infection
- Tsutsui Toshio
- 2022-11-25
Recruiting
- M21-410, Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of ABBV-514 Alone or in Combination With Budigalimab
- Non-Small Cell Lung Cancer; Head and Neck Squamous Cell Carcinoma; Other Solid Tumors
- Tsutsui Atsuko
- 2021-10-22
Other
- EN-SEMBLE
- HER2-positive unresectable and/or recurrent breast cancer
- Tsurutani Junji
- 2022-12-12
Not yet recruiting
- Investigation of the use of nasal cannula fixtures
Questionnaire survey of patients regarding the presence or absence of medical device-related pressure injuries, safety, and usability
- Pneumonia, chronic obstructive pulmonary disease, interstitial pneumonia, respiratory failure, pulmo
- Tsuruta Kaori
- 2022-12-16
Recruiting
- A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- Chronic Obstructive Pulmonary Disease (COPD)
- Tsurumaki Sachi
- 2024-02-07
Recruiting
- A study to test how different doses of BI 1703880 in combination with ezabenlimab are tolerated in people with different types of advanced cancer (solid tumours)
- advanced, unresectable and/or metastatic solid tumours
- Tsunoda Toru
- 2023-01-27
Not yet recruiting
- DAREON-8: A study to test how well different doses of
BI 764532 in addition to standard of care are tolerated by people
with advanced small cell lung cancer
- Histologically or cytologically confirmed ES-SCLC
- Tsunoda Toru
- 2024-02-01
Other
- A study to test whether different combinations of BI 765063, ezabenlimab, chemotherapy, cetuximab, and BI 836880 help people with head and neck cancer or liver cancer
- Patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) or hepatocellular c
- Tsunoda Toru
- 2022-03-08